🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

RecruitingNAAges 18 Years - anyAllAmsterdam UMC
NCT06679920 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age \> 18 years. * Have at least 1 suspected bladder tumour seen at cystoscopy. * Have a bladder that is accessible for cystoscopy. * Be in a physical condition to undergo a TURBT. * Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention. Exclusion Criteria: * Pregnant or lactating women. * The only tumour site is at the bladder neck. * The tumour(s) is larger than 2 centimetres in diameter. * \>5 tumours present. * Solely a suspected flat lesion present.
💊

What it tests

  • Optical coherence tomography
📍

Where

2 sites
Amsterdam University Medical Center
Amsterdam, Netherlands
Amsterdam University Medical Center
Amsterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy